Interim report January – June 2007

• Net sales in the second quarter amounted to 131.1 MSEK (128.3) and to 250.0 MSEK (249.0) in the period January – June. At comparable exchange rates and excluding the Chem Dev product area which is being closed down sales increased by 8% in both periods.

• The operating result for the second quarter amounted to 11.1 MSEK (-2.2). The operating result for the first six months 2007 amounted to 18.3 MSEK (-14.3).

• Profit after tax for the second quarter amounted to 38.1 MSEK (4.0) and earnings per share to 0.43 SEK (0.04).

• In the second quarter capitalization of deferred income taxes recoverable was made to the amount of 27.6 MSEK.

• For the period January – June 2007 net profit amounted to 45.3 MSEK (-16.8) and earnings per share to 0.51 SEK (-0.19).

• Biotage has signed an agreement with one of China’s leading contract research companies, Shanghai Chempartner Co., Ltd. concerning the delivery of instruments. The order has a value of approx. 10 million SEK, making this Biotage’s single largest order from China to date.

• A new market segment, Molecular Imaging, was introduced.